CDKN2A and breast carcinoma: In the present work, we assessed the expression of cyclin D1, CDK4 and p16 in human invasive ductal mammary carcinoma samples, correlated the findings with the known prognostic factors for breast cancer and investigated the correlations of these three markers with survival functions.